Please login to the form below

Not currently logged in
Email:
Password:

hepatitis C

This page shows the latest hepatitis C news and features for those working in and with pharma, biotech and healthcare.

Roche's O’Day swaps big pharma for big biotech

Roche's O’Day swaps big pharma for big biotech

business.”. Daniel O'Day: tasked with taking Gilead forward after hep C franchise declines. ... The new CEO's main task will be to ensure the company's revenues can grow again, as its once-record-breaking hepatitis C (HCV) franchise continues to

Latest news

More from news
Approximately 96 fully matching, plus 238 partially matching documents found.

Latest Intelligence

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    Most of our medicines in Europe are available at the same time, at generic prices, in Africa – in hepatitis C, the drugs are available earlier in Africa than Europe because of

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Meanwhile, the pharma industry is hitting new heights in drug innovation, including cures for diseases such as hepatitis C, haemophilia and huge progress in cancer and cell and gene therapy - but

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    on hepatitis C treatments and the recent introduction of the Budget Impact Test.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

More from intelligence
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics